In this issue we are presenting the second installment of our new quarterly feature—a statistical review compiled from Windhover's Strategic Transactions Databaseof the deal activity within the pharmaceutical/biotechnology, medical device, and in vitro diagnostics industries.
Some notes about our coverage: we have limited this review to human health care (thus no animal health or agricultural transactions); to mergers and acquisitions where a definitive agreement has...